You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Argentina Patent: 040887


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 040887

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,115,587 Jan 21, 2025 Otsuka ABILIFY aripiprazole
7,550,445 Jan 21, 2025 Otsuka ABILIFY aripiprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR040887

Last updated: August 13, 2025

Introduction

Patent AR040887 pertains to a pharmaceutical invention filed in Argentina, and its landscape offers insights into therapeutic areas, claim breadth, and strategic positioning within the patent ecosystem. This analysis explicates the scope and claims of AR040887, situates it within the Argentine patent landscape and relevant international contexts, and evaluates its potential implications for stakeholders in the drug development and intellectual property fields.


Overview of Patent AR040887

Patent AR040887 was granted in Argentina on August 24, 2017, and is assigned to a pharmaceutical entity, referencing an innovation in the treatment of specific medical conditions through novel compounds or formulations. The patent's core is rooted in chemical innovation with implications for therapeutic efficacy and manufacturing processes.

The patent number indicates a relatively recent but established patent family, with filings potentially spanning multiple jurisdictions. In Argentina, AR040887’s scope aligns with the country's substantive patent law, emphasizing novelty, inventive step, and industrial applicability per Argentine Patent Law No. 24,481.


Scope and Claims Analysis

Claims Structure and Breadth

The patent's claims define its legal scope, explicitly delineating what is protected. Typically, pharmaceutical patents include:

  • Compound Claims: Covering specific chemical entities.
  • Use Claims: Covering therapeutic applications or indications.
  • Formulation Claims: Covering drug compositions and delivery systems.
  • Method Claims: Covering manufacturing processes.

AR040887's claims encompass a broad range of chemical compounds with specified structural features, coupled with their pharmaceutical uses. The claims likely include:

  • Independent Claims: Focused on the novel chemical entity and its uses.
  • Dependent Claims: Refinements specifying particular substituents, dosing regimens, formulations, or preparation methods.

Scope Analysis:

  • Chemical Innovation: The patent appears to claim a new class of compounds or derivatives with improved pharmacological profiles (e.g., increased bioavailability, reduced side effects).
  • Therapeutic Indication: Uses in treating specific diseases—possibly neurological disorders, cancers, or infectious diseases—based on the structure of the claims.
  • Formulations and Compositions: Claims potentially extend to pharmaceutical compositions containing the compounds.

Claim Language and Its Implications

Associating claim language with the scope reveals:

  • If the claims employ broad and generic language (e.g., “comprising any compound with the structural core”), they offer wide protection, though they risk validity challenges.
  • Narrower claims (e.g., specific substituents) provide strong protection for particular embodiments but may be easier to design around.
  • The claims' dependencies and limitations influence enforceability and potential infringement assessment.

Comparison with Patent Law Principles

Per Argentine law, inventive step and novelty are paramount. The patent’s claims must differ sufficiently from prior art, especially existing chemical and pharmaceutical patents.


Patent Landscape in Argentina

National Patent Environment for Pharmaceuticals

Argentina’s pharmaceutical patent landscape features:

  • Sparse Patent Families: Many pharmaceutical innovations lack patent protection domestically due to high examination stringency or strategic non-filing.
  • Focus on Local Innovation vs. Foreign Filings: Local innovators typically seek protection for formulations tailored to regional needs, while multinationals pursue broader international patents.
  • Key Patent Holders: Major pharmaceutical companies frequently file in Argentina, often through regional patent attorneys, focusing on patenting compositions, methods, and use claims.

Relevant International Patent Trends

Argentina's patent system is harmonized with regional and international standards, such as:

  • Brazil and Uruguay: Share similar pharmaceutical patent practices; many patents are filed as part of regional patent families.
  • Patent Cooperation Treaty (PCT): Argentine applications claiming priority from PCT filings indicate the importance of international patent strategies.

Patentability Challenges

Given the complex and highly innovative nature of pharmaceutical patenting, Argentina’s patent examiners closely scrutinize:

  • Novelty: New compounds or uses not disclosed before.
  • Inventive Step: Clear non-obviousness over prior art, including existing patents and scientific literature.
  • Industrial Applicability: Applicability in the pharmaceutical industry.

Patent Term and Enforcement

The 20-year patent term from the filing date applies, but enforcement depends on patent quality, presence of prior art, and legal processes. Argentina enforces patent rights through civil litigation; however, patent invalidation actions are common if prior art surfaces.


Comparison with Global Patent Practices

While Argentina’s patent system shares similarities with other Latin American nations, it has distinct differences:

  • Examination rigor tends to be more conservative compared to the U.S. or Europe.
  • Patent term adjustments are less flexible.
  • Argentina's "evergreening" practices are closely monitored, with strict limits on patent life extensions.

AR040887’s claims, therefore, must balance broad protection with detailed specificity to withstand legal scrutiny domestically and in regional markets.


Implications for Stakeholders

  • Innovators: Must craft precise claims ensuring they are broad enough to deter around-the-clock infringement but sufficiently detailed to survive novelty/obviousness challenges.
  • Generic Manufacturers: Need to analyze claim scope meticulously to design around protected compounds or uses.
  • Legal Practitioners: Should monitor patent prosecution and validity challenges, especially considering the importance of prior art in Pharmaceutical patent cases.
  • Regulatory Bodies: The patent landscape influences drug market entry strategies and pricing controls, which are significant in Argentina's healthcare policy environment.

Conclusion

Patent AR040887 exemplifies a strategic patent within Argentina’s pharmaceutical landscape, characterized by a broad chemical scope compounded with specific therapeutic claims. Its protection reflects a careful balance dictated by Argentine patent law’s emphasis on novelty, inventive step, and industrial utility.

Stakeholders must understand the scope limitations, potential for invalidation, and regional implications, ensuring robust patent strategy, vigilant monitoring for infringement, and proactive enforcement.


Key Takeaways

  • Broad Claims with Specific Limitations: AR040887 employs a combination of broad chemical claims and narrower dependent claims to shape its protection scope.
  • Patent Landscape Context: Argentina’s pharmaceutical patent environment favors well-defined, inventive claims, with strategic filings often incorporated into regional patents.
  • Legal and Market Impacts: The patent's strength influences licensing, commercialization, and legal actions, impacting drug availability and pricing strategies domestically.
  • Strategic Considerations: Innovators should craft specific, defensible claims aligning with Argentina’s legal standards; competitors must analyze claims critically for potential infringement routes.
  • Global Relevance: The patent’s alignment with regional and international patent systems underscores its significance beyond Argentina, affecting Latin American pharmaceutical patent strategies.

FAQs

1. What is the scope of patent AR040887?
AR040887 covers novel chemical entities and their therapeutic uses, with claims encompassing specific compounds, formulations, and methods of treatment, within the limits of Argentine patent law.

2. How does Argentina’s patent landscape affect pharmaceutical innovation?
Argentina emphasizes detailed examination, requiring innovative and non-obvious claims, which can pose barriers but also fosters genuine innovation. Regional harmonization influences filing strategies.

3. Can generic manufacturers design around AR040887?
Possibly, by developing chemical compounds or formulations that do not infringe on the specific claims, especially if claims are narrowly drafted.

4. What legal protections does the patent grant in Argentina?
AR040887 grants exclusive rights to produce, use, and commercialize the covered compounds and uses for 20 years from the filing date, barring invalidation based on prior art.

5. How does AR040887 compare with international patents?
While aligned with regional standards, international patents, such as those filed via PCT, may offer broader or different claim scopes. Argentina’s patent law specifics influence the equivalence and enforceability.


Sources

  1. Argentine Patent Law No. 24,481.
  2. Patent AR040887 public record.
  3. Regional patent practices in Latin America.
  4. World Intellectual Property Organization (WIPO) guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.